Tag: amyloid hypothesis

New Review Casts Doubt On Alzheimers Drugs But Is Controversial

There's a lot less than meets the eye to a recent Cochrane review that casts doubt on the efficacy of drugs for Alzheimer's disease.

/ April 22, 2026

FDA Advisory Committee Recommends approval of new Alzheimer’s drug Donanemab

If approved, donanemab would be the third FDA approved disease-modifying beta-amyloid treatment for Alzheimer’s disease.

/ June 23, 2024